Cerus Corporation
Phase 3 Estimated
Undisclosed program
Anemia
Countdown
25days
Phase 3 readout Β· Jul 31, 2026
What's at stake Phase 3 trial results for Undisclosed program in Anemia are due Jul 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
β€œCT.gov NCT03037164: Phase 3 trial, sponsor Cerus Corporation. Primary completion date 2026-07-31 (estimated).”

Provenance

1 source on file. Trial NCT03037164.

Link copied βœ“